BC SW LP 13D and 13G filings for SpringWorks Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-03-20 5:01 pm Sale |
2023-03-16 | 13D | SpringWorks Therapeutics, Inc. SWTX |
BC SW LP | 3,081,307 4.900% |
-1,750,000![]() (-36.22%) |
Filing |
2022-09-13 4:30 pm Unchanged |
2022-09-09 | 13D | SpringWorks Therapeutics, Inc. SWTX |
BC SW LP | 4,831,307 8.000% |
0 (Unchanged) |
Filing |
2021-08-12 5:07 pm Sale |
2021-08-10 | 13D | SpringWorks Therapeutics, Inc. SWTX |
BC SW LP | 4,831,307 9.800% |
-1,000,000![]() (-17.15%) |
Filing |
2021-03-11 4:30 pm Sale |
2021-03-09 | 13D | SpringWorks Therapeutics, Inc. SWTX |
BC SW LP | 5,831,307 11.900% |
-1,450,000![]() (-19.91%) |
Filing |
2020-10-15 5:20 pm Unchanged |
2020-10-13 | 13D | SpringWorks Therapeutics, Inc. SWTX |
BC SW LP | 7,281,307 15.000% |
0 (Unchanged) |
Filing |